These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7692632)

  • 1. Persistence of donor lymphocytes in liver allograft recipients.
    Schlitt HJ; Kanehiro H; Raddatz G; Steinhoff G; Richter N; Nashan B; Ringe B; Wonigeit K; Pichlmayr R
    Transplantation; 1993 Oct; 56(4):1001-7. PubMed ID: 7692632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passenger lymphocytes in human liver allografts and their potential role after transplantation.
    Schlitt HJ; Raddatz G; Steinhoff G; Wonigeit K; Pichlmayr R
    Transplantation; 1993 Oct; 56(4):951-5. PubMed ID: 8105572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.
    Qian S; Lu L; Fu F; Li W; Pan F; Steptoe RJ; Chambers FG; Starzl TE; Fung JJ; Thomson AW
    Transplantation; 1998 Jun; 65(12):1590-8. PubMed ID: 9665075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome.
    Moroso V; van der Meer A; Tilanus HW; Kazemier G; van der Laan LJ; Metselaar HJ; Joosten I; Kwekkeboom J
    Transpl Int; 2011 Sep; 24(9):932-42. PubMed ID: 21672051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
    Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
    Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell and alphabeta and gammadelta lymphocyte traffic into the liver graft immediately after liver transplantation.
    Navarro F; Portalès P; Candon S; Pruvot FR; Pageaux G; Fabre JM; Domergue J; Clot J
    Transplantation; 2000 Feb; 69(4):633-9. PubMed ID: 10708122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor cell chimerism, host lymphocyte phenotype and allograft acceptance.
    Wu L; Sun J; Wang C; Qin G; Koutalistras N; Sheil AG
    Transplant Proc; 2000 Nov; 32(7):2043-4. PubMed ID: 11120058
    [No Abstract]   [Full Text] [Related]  

  • 13. Alloreactivity of natural killer cells in allogeneic liver transplantation.
    Oertel M; Kohlhaw K; Diepolder HM; Schröder S; Schwarz R; Tannapfel A; Mössner J; Hauss J; Berr F
    Transplantation; 2001 Jul; 72(1):116-22. PubMed ID: 11468545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation.
    Mathew JM; Marsh JW; Susskind B; Mohanakumar T
    J Clin Invest; 1993 Mar; 91(3):900-6. PubMed ID: 8450068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of donor lymphocytes in human hepatic grafts with immune activation but no clinical rejection.
    Kanehiro H; Steinhoff G; Nashan B; Pichlmayr R; Schlitt HJ
    Transplant Proc; 1993 Apr; 25(2):1764-5. PubMed ID: 7682350
    [No Abstract]   [Full Text] [Related]  

  • 16. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts.
    Roelen DL; van Beelen E; van Bree SP; van Rood JJ; Völker-Dieben HJ; Claas FH
    Transplantation; 1995 Apr; 59(7):1039-42. PubMed ID: 7709440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of stable intragraft cell chimerism in rat liver allografts after drug-induced tolerance.
    Gassel HJ; Otto C; Klein I; Steger U; Meyer D; Gassel AM; Timmermann W; Ulrichs K; Thiede A
    Transplantation; 2001 Jun; 71(12):1848-52. PubMed ID: 11455268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study.
    Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO
    Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model.
    Erdag G; Morgan JR
    Transplantation; 2002 Feb; 73(4):519-28. PubMed ID: 11889422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.